Livzon Pharmaceutical Group(HK:1513)
HK$24.980.00 (0.00%)
HK:1513
Livzon Pharmaceutical Group earnings date
HK$24.98
At close:0.00 (0.00%)
Want to see HK:1513 full AI Analyst Report?
Livzon Pharmaceutical Group (1513) Q2 2025 Earnings Report
1 Followers
HK:1513 Q2 2025 EPS Results
- Actual EPS
- HKD 0.77
- Consensus EPS
- HKD 0.63
- Beat/Miss
- Beat by +HKD 0.13
- One Year Ago EPS
- HKD 0.63
HK:1513 Q2 2025 Revenue Results
- Actual Revenue
- HKD 3.34B
- Expected Revenue
- HKD 3.68B
- Beat/Miss
- Missed by -HKD 346.48M
- YoY Revenue Growth
- +1.66%
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 08/20/2025
- Time
- Before Open
- Conference Call
- Wednesday, August 20, 2025
HK:1513 Upcoming Earnings
Livzon Pharmaceutical Group's next earnings date is estimated for March 31, 2027, based on past reporting schedules.
Q2 2025 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
HK:1513 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 31, 2027 | 2026 (Q4) | 0.41- | 0.33 | ― | ― |
| Oct 23, 2026 | 2026 (Q3) | 0.570.47 | 0.58 | -18.70% (-0.11) | |
| Aug 21, 2026 | 2026 (Q2) | 0.710.45 | 0.77 | -41.96% (-0.32) | |
| Apr 23, 2026 | 2026 (Q1) | 0.800.72 | 0.79 | -8.33% (-0.07) | |
| Mar 24, 2026 | 2025 (Q4) | 0.410.33 | 0.48 | -30.22% (-0.14) | |
| Oct 23, 2025 | 2025 (Q3) | 0.670.58 | 0.6 | -3.72% (-0.02) | |
| Aug 20, 2025 | 2025 (Q2) | 0.630.77 | 0.63 | 20.93% (+0.13) | |
| Apr 23, 2025 | 2025 (Q1) | 0.780.79 | 0.72 | 9.09% (+0.07) | |
| Mar 26, 2025 | 2024 (Q4) | 0.400.48 | 0.42 | 13.06% (+0.06) | |
| Oct 23, 2024 | 2024 (Q3) | 0.630.60 | 0.56 | 8.03% (+0.04) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

